Iranian Journal of Basic Medical Sciences، جلد ۲۶، شماره ۳، صفحات ۳۴۳-۳۵۰

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Cannabidiol interacts with the FXR/Nrf2 pathway and changes the CB1/CB2 receptors ratio in gentamicin-induced kidney injury in rats
چکیده انگلیسی مقاله Objective(s): Gentamicin-induced nephrotoxicity was used as an experimental model of kidney disease. The present study was performed to assess the therapeutic role of cannabidiol (CBD) against gentamicin-induced renal damage. Materials and Methods: Forty two male Wistar rats were randomly allocated into 6 groups (n=7), including: (1) Control, (2) Vehicle, (3) Gentamicin-treated group (100 mg/kg/day) for 10 days (GM), (4-6) 3 Gentamicin-CBD-treated groups (2.5, 5, and 10 mg/kg/day) for 10 days (GM+CBD2.5, GM+CBD5, GM+CBD10). Serum levels of BUN and Cr, renal histology as well as real-time qRT-PCR were used to investigate the pattern of changes at different levels.Results: Gentamicin increased serum BUN and Cr (P< 0.001), down-regulation of FXR (P< 0.001), SOD (P< 0.05) and up-regulation of CB1 receptor mRNA (P< 0.01). Compared to the control group, CBD at 5 decreased (P< 0.05) and at 10 mg/kg/day increased the expression of FXR (P< 0.05). Nrf2 expression in CBD groups was increased (P< 0.001 vs. GM). The expression of TNF-α compared to the control and GM groups, was significantly increased in CBD2.5 (P< 0.01) and CBD10 (P< 0.05). Compared to the control, CBD at 2.5 (P< 0.01), 5 (P< 0.001) and 10 (P< 0.001) mg/kg/day significantly increased the expression of CB1R. Up-regulation of CB1R in the GM+CBD5, was significantly higher (P< 0.05) than the GM group. Compared to the control group, the most significant increase in CB2 receptor expression was observed at CBD10 (P< 0.05). Conclusion: CBD particularly at 10 mg/kg/day might be of significant therapeutic benefit against such renal complications. Activating the FXR/Nrf2 pathway and counteracting the deleterious effects of CB1 receptors via CB2 receptors scale-up could be part of the protective mechanisms of CBD. 
کلیدواژه‌های انگلیسی مقاله Cannabidiol, CB1 receptors, CB2 Receptors, Farnesoid receptors, Gentamicin, Nrf2

نویسندگان مقاله | Vahideh Hokmabady
Department of Physiology, School of Medicine, Arak University of Medical Sciences, Arak, Iran


| Azadeh Khalili
Department of Physiology, Pharmacology, Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran


| Seyed Ali Hashemi
Department of Pathology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran


| Keshvad Hedayatyanfard
Department of Physiology, Pharmacology, Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran


| Soraya Parvari
Department of Anatomical Sciences, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran


| Saeed Changizi-Ashtiyani
Department of Physiology, School of Medicine, Arak University of Medical Sciences, Arak, Iran


| Gholamreza Bayat
Department of Physiology, Pharmacology, Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran



نشانی اینترنتی https://ijbms.mums.ac.ir/article_21730.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات